Clinical Trials Browser

OTHER × Carcinoma, Neuroendocrine × toripalimab × Clear all

NCT03992911 2019-06-20

Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma

Phase 2/3 Unknown

Carcinoma, Neuroendocrine